Brian Talbot

454 citations

26 papers · 380 · h-index 13

Impact in

Toxicology top 1%
- Forensic Toxicology and Drug Analysis
Cellular and Molecular Neuroscience
- Neurotransmitter Receptor Influence on Behavior

Papers in

Toxicology 14
- Forensic Toxicology and Drug Analysis 14
Clinical Psychology 10
- Psychedelics and Drug Studies 10

Co-authors: Pierce V. Kavanagh (20 shared papers)John D. Power (15 shared papers)John E. O’Brien (15 shared papers)Simon D. Brandt (12 shared papers)Brendan Twamley (9 shared papers)Geraldine Dowling (9 shared papers)Seán D. McDermott (4 shared papers)John Walsh (4 shared papers)
Journals: Drug Testing and Analysis (17 papers)The FASEB Journal (3 papers)Journal of Forensic Sciences (1 paper)Rapid Communications in Mass Spectrometry (1 paper)Pharmaceutics (1 paper)
Partner nations: Ireland United Kingdom United States

In The Last Decade

Brian Talbot

26 papers receiving 372 citations

Peers

Countries citing papers authored by Brian Talbot

Since Specialization

Citations

This map shows the geographic impact of Brian Talbot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Talbot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Talbot more than expected).

Fields of papers citing papers by Brian Talbot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Talbot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Talbot. The network helps show where Brian Talbot may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian Talbot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian Talbot Line = papers co-authored together Brian Talbot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	HPLC profiling of Mimosa pudica polyphenols and their non-invasive biophysical investigations for anti-dermatoheliotic and skin reinstating potential Biomedicine & Pharmacotherapy ·S. Ijaz, Haji Muhammad Shoaib Khan, Zeeshan Anwar, Brian Talbot, John Walsh	2018	45
2	Doxorubicin Loading into Milk and Mesenchymal Stem Cells’ Extracellular Vesicles as Drug Delivery Vehicles Pharmaceutics ·Anindya Mukhopadhya, Dimitrios Tsiapalis, Niamh McNamee, Brian Talbot, Lorraine O’Driscoll	2023	42
3	Characterization of a novel and potentially lethal designer drug (±)‐cis‐para‐methyl‐4‐methylaminorex (4,4'‐DMAR, or ‘Serotoni’) Drug Testing and Analysis ·Simon D. Brandt, Michael H. Baumann, John S. Partilla, Pierce V. Kavanagh, John D. Power, Brian Talbot, Brendan Twamley, Olivia Mahony, John O’Brien, Simon Elliott, Roland Archer, Julian Patrick, Kuldip Singh, Nicola M. Dempster, Simon H. Cosbey	2014	31
4	The analysis of amphetamine‐like cathinone derivatives using positive electrospray ionization with in‐source collision‐induced dissociation Rapid Communications in Mass Spectrometry ·John D. Power, Seán D. McDermott, Brian Talbot, John E. O’Brien, Pierce V. Kavanagh	2012	28
5	Test purchase, synthesis, and characterization of 2‐methoxydiphenidine (MXP) and differentiation from its meta‐ and para‐substituted isomers Drug Testing and Analysis ·Gavin McLaughlin, Noreen Morris, Pierce V. Kavanagh, John D. Power, John E. O’Brien, Brian Talbot, Simon Elliott, Jason Wallach, Khoa Hoang, Hamilton Morris, Simon D. Brandt	2015	26
6	Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N‐methoxy positional isomer, N‐methoxymephedrone Drug Testing and Analysis ·Gavin McLaughlin, Noreen Morris, Pierce V. Kavanagh, John D. Power, Geraldine Dowling, Brendan Twamley, John O’Brien, Brian Talbot, Donna Walther, John S. Partilla, Michael H. Baumann, Simon D. Brandt	2016	20
7	‘Smoking’ mephedrone: The identification of the pyrolysis products of 4‐methylmethcathinone hydrochloride Drug Testing and Analysis ·Pierce V. Kavanagh, John E. O’Brien, John D. Power, Brian Talbot, Seán D. McDermott	2012	17
8	The synthesis and characterization of the ‘research chemical’ N‐(1‐amino‐3‐methyl‐1‐oxobutan‐2‐yl)‐1‐(cyclohexylmethyl)‐3‐(4‐fluorophenyl)‐1H‐pyrazole‐5‐carboxamide (3,5‐AB‐CHMFUPPYCA) and differentiation from its 5,3‐regioisomer Drug Testing and Analysis ·Gavin McLaughlin, Noreen Morris, Pierce V. Kavanagh, John D. Power, Brendan Twamley, John O’Brien, Brian Talbot, Geraldine Dowling, Simon D. Brandt	2015	16
9	Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3′,4′‐methylenedioxy‐4‐methylaminorex (MDMAR) Drug Testing and Analysis ·Gavin McLaughlin, Noreen Morris, Pierce V. Kavanagh, John D. Power, Brendan Twamley, John E. O’Brien, Brian Talbot, Geraldine Dowling, Olivia Mahony, Simon D. Brandt, Julian Patrick, Roland Archer, John S. Partilla, Michael H. Baumann	2014	15
10	Forensic analysis of P2P derived amphetamine synthesis impurities: identification and characterization of indene by‐products Drug Testing and Analysis ·John D. Power, Pierce V. Kavanagh, Gavin McLaughlin, Geraldine Dowling, Michael Barry, John E. O’Brien, Brian Talbot, Brendan Twamley, Simon D. Brandt	2016	14
11	Analytical characterization of N,N‐diallyltryptamine (DALT) and 16 ring‐substituted derivatives Drug Testing and Analysis ·Simon D. Brandt, Pierce V. Kavanagh, Geraldine Dowling, Brian Talbot, Folker Westphal, Markus R. Meyer, Hans H. Maurer, Adam L. Halberstadt	2016	13
12	Characterization of the pyrolysis products of methiopropamine Drug Testing and Analysis ·Emily D. Bouso, Elizabeth Gardner, John E. O’Brien, Brian Talbot, Pierce V. Kavanagh	2013	13
13	Test purchase, synthesis and characterization of 3‐fluorophenmetrazine (3‐FPM) and differentiation from its ortho‐ and para‐substituted isomers Drug Testing and Analysis ·Gavin McLaughlin, Noreen Morris, Pierce V. Kavanagh, Geraldine Dowling, John D. Power, Brendan Twamley, John E. O’Brien, Brian Talbot, Harald H. Sitte, Simon D. Brandt	2016	12
14	The identification of an impurity product, 4,6-dimethyl-3,5-diphenylpyridin-2-one in an amphetamine importation seizure, a potential route specific by-product for amphetamine synthesized by the APAAN to P2P, Leuckart route Forensic Science International ·John D. Power, John E. O’Brien, Brian Talbot, Michael Barry, Pierce V. Kavanagh	2014	12
15	Test purchase, identification and synthesis of 2‐amino‐1‐(4‐bromo‐2, 5‐dimethoxyphenyl)ethan‐1‐one (bk‐2C‐B) Drug Testing and Analysis ·John D. Power, Pierce V. Kavanagh, John O’Brien, Michael Barry, Brendan Twamley, Brian Talbot, Geraldine Dowling, Simon D. Brandt	2014	11
16	Identification of (2‐aminopropyl)indole positional isomers in forensic samples Drug Testing and Analysis ·Kenneth R. Scott, John D. Power, Seán D. McDermott, John E. O’Brien, Brian Talbot, Michael Barry, Pierce V. Kavanagh	2013	11
17	The Psilocin (4‐hydroxy‐N,N‐dimethyltryptamine) and Bufotenine (5‐hydroxy‐N,N‐dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified Journal of Forensic Sciences ·Tehila Mishraki‐Berkowitz, Esti Kochelski, Pierce V. Kavanagh, John E. O’Brien, Clodagh Dunne, Brian Talbot, Patricia Ennis, Udi Wolf	2020	10
18	Identification of pyrolysis products of the new psychoactive substance 2‐amino‐1‐(4‐bromo‐2,5‐dimethoxyphenyl)ethanone hydrochloride (bk‐2C‐B) and its iodo analogue bk‐2C‐I Drug Testing and Analysis ·Kelly B. Texter, Rachel Waymach, Pierce V. Kavanagh, John E. O’Brien, Brian Talbot, Simon D. Brandt, Elizabeth Gardner	2017	9
19	The syntheses, characterization and in vitro metabolism of nitracaine, methoxypiperamide and mephtetramine Drug Testing and Analysis ·John D. Power, Kenneth R. Scott, Elizabeth Gardner, Bronagh M. Curran McAteer, John E. O’Brien, Margaret Brehon, Brian Talbot, Pierce V. Kavanagh	2014	8
20	Head shop 'legal highs' active consituents identification chart (July-August 2010, '714' - '823'). Scientific Repository (Petra Christian University) ·Pierce Kavanagh, Paul Spiers, John O’Brien, Sinéad McNamara, Daniel Angelov, Daniel Mullan, Brian Talbot, Sheila Ryder	2010	7

About Brian Talbot

Brian Talbot is a scholar working on Toxicology, Clinical Psychology, Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology, having authored 26 papers that have together received 380 indexed citations. Recurring topics across this work include Forensic Toxicology and Drug Analysis (14 papers), Psychedelics and Drug Studies (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers), Cannabis and Cannabinoid Research (4 papers), Nicotinic Acetylcholine Receptors Study (3 papers), Fungal Biology and Applications (3 papers), Analytical Chemistry and Chromatography (3 papers) and Mass Spectrometry Techniques and Applications (2 papers). The work is most often cited by research in Toxicology (183 citations), Cellular and Molecular Neuroscience (108 citations), Drug Discovery (1 citation), Clinical Psychology (107 citations) and Biological Psychiatry (8 citations). Brian Talbot has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Pierce V. Kavanagh, John D. Power, John E. O’Brien, Simon D. Brandt, Brendan Twamley, Geraldine Dowling, Seán D. McDermott, John Walsh, S. Ijaz and Haji Muhammad Shoaib Khan. Their work appears in journals such as Drug Testing and Analysis, The FASEB Journal, Journal of Forensic Sciences, Rapid Communications in Mass Spectrometry and Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Brian Talbot

Impact in

Papers in i

In The Last Decade

Brian Talbot

Peers

Countries citing papers authored by Brian Talbot

Fields of papers citing papers by Brian Talbot

All Works

About Brian Talbot

Explore authors with similar magnitude of impact

Papers in